Size-selective hemoperfusion polymeric adsorbents
Size-selective hemocompatible porous polymeric adsorbents are provided with a pore structure capable of excluding molecules larger than 50,000 Daltons, but with a pore system that allows good ingress and egress of molecules smaller than 35,000 Daltons. The pore system in these porous polymeric adsorbents is controlled by the method of synthesis so that 98% of the total pore volume is located in pores smaller than 300 Angstroms (Å) in diameter with a working pore size range within 100 to 300 Å in diameter. The porous polymeric adsorbents of this invention are very selective for extracting midsize proteins, such as cytokines and β 2 -microglobulin, from blood and other physiologic fluids while keeping the components required for good health such as cells, platelets, albumin, hemoglobin, fibrinogen, and other serum proteins intact.
1. A size-selective porous polymer comprising of a plurality of pores, wherein all of said pores of said polymer have diameters from greater than 100 Angstrom to about 300 Angstrom, said polymer being capable of sorbing protein molecules greater than 20,000 to less than 50,000 Daltons from blood and excluding the sorption of blood proteins greater than 50,000 Daltons, said polymer having an effective pore volume and a capacity pore volume, said effective pore volume is from at least 0.306 cc/g to 0.986 cc/g, said effective pore volume is from at least 21.97% to 98.16% of said polymer's capacity pore volume, said effective pores having diameters from greater than 100 Angstroms to about 250 Angstroms and said polymer having oversized pores with a diameter greater than 251 Angstroms.
2. The polymer of claim 1 wherein said polymer is biocompatible.
3. The polymer of claim 1 wherein said polymer is hemocompatible.
4. The polymer of claim 1 wherein the geometry of said polymer is a spherical bead.
5. The polymer of claim 1 wherein said polymer is used in direct contact with whole blood to sorb protein molecules selected from a group consisting essentially of cytokines and β 2 -microglobulin and exclude the sorption of large blood proteins, said large blood proteins being selected from a group consisting essentially of hemoglobin, albumin, immunoglobulins, fibrinogen, serum proteins and other blood proteins larger than 50,000 Daltons.
6. The polymer of claim 1 wherein said polymer has an internal surface selectivity for adsorbing proteins smaller than 50,000 Daltons, having little to no selectivity for adsorbing vitamins, glucose, electrolytes, fats, and other hydrophilic small molecular nutrients carried by the blood.
7. The polymer of claim 1 wherein said polymer is made using suspension polymerization.
8. The polymer of claim 1 wherein said polymer is constructed from aromatic monomers of styrene and ethylvinylbenzene with a crosslinking agent selected from a group consisting essentially of divinylbenzene, trivinylcyclohexane, trivinylbenzene, divinylnaphthalene, divinylsulfone, trimethylolpropane triacrylate, trimethylolpropane trimethacrylate and mixtures thereof.
9. The polymer in claim 8 wherein a stabilizing agent for the droplet suspension polymerization is selected from a group consisting essentially of hemocompatibilizing polymers, said polymers being poly(N-vinylpyrrolidinone), poly(hydroxyethyl acrylate), poly(hydroxyethyl methacrylate), hydroxylethyl cellulose, hydroxypropyl cellulose, salts of poly(acrylic acid), salts of poly(methacrylic acid), poly(dimethylaminoethyl acrylate), poly(dimethylaminoethyl methacrylate), poly(diethylaminoethyl acrylate), poly(diethylaminoethyl methacrylate), poly(vinyl alcohol) and mixtures thereof.
10. The polymer of claim 1 wherein said polymer is made hemocompatible by exterior coatings selected from a group consisting essentially of poly(N-vinylpyrrolidinone), poly(hydroxyethyl acrylate), poly(hydroxyethyl methacrylate), hydroxyethyl cellulose, hydroxypropyl cellulose, salts of poy(acrylic acid), salts of poly(methacrylic acid), poly(dimethylaminoethyl methacrylate), poly(dimethylaminoethyl acrylate), poly(diethylaminoethyl acrylate), poly(diethylaminoethyl methacrylate), poly(vinyl alcohol) and mixtures thereof.
11. The polymer of claim 10 wherein said polymer is made hemocompatible by surface grafting of the hemocompatible exterior coatings concomitantly with formation of the porous polymer beads.
12. The polymer of claim 10 wherein said polymer is made hemocompatible by surface grafting of the hemocompatible exterior coatings onto the preformed porous polymeric beads.
13. A size selective polymer comprising of a plurality of pores wherein all of said pores have diameters from greater than 100 Angstrom to about 300 Angstrom, said polymer designed to sorb cytokines and β 2 -microglobulin and exclude the sorption of large blood borne proteins, said large blood borne proteins being selected from a group consisting essentially of hemoglobin, albumin, immunoglobulins, fibrinogen, serum proteins and other blood proteins larger than 50,000 Daltons, said polymer having an effective pore volume of at least 0.306 cc/g to 0.986 cc/g, said effective pores having diameters from greater than 100 Angstroms to about 250 Angstroms and said polymer having oversized pores with a diameter greater than 251 Angstroms.
14. The polymer of claim 13 wherein said polymer is made using suspension polymerization.
15. The polymer of claim 13 wherein said polymer is made porous using macroreticular synthesis.
16. The polymer of claim 13 wherein said polymer has an internal surface selectivity for adsorbing proteins smaller than 50,000 Daltons, having little to no selectivity for adsorbing vitamins, glucose, electrolytes, fats, and other hydrophilic small molecular nutrients carried by the blood.
17. A polymer comprising of a plurality of pores, wherein all of said pores of said polymer have diameters from greater than 75 Angstrom to about 300 Angstrom, said polymer being capable of sorbing protein molecules greater than 20,000 Daltons from blood and excluding the sorption of blood proteins greater than 50,000 Daltons, said polymer having an effective pore volume and a capacity pore volume, said effective pore volume is at least 21.97% to 98.16% of said polymer's capacity pore volume, said effective pores having diameters from greater than 100 Angstroms to about 250 Angstroms and said polymer having oversized pores with a diameter greater than 251 Angstroms.